Stock screener

LMAT

Conviction 38HealthcareScan · Mon, Aug 10, 2026
Bearish harami
LMAT$81.12-0.41%
ResistanceSupportVol 14Insider sell
63 bars
Vol MA14 546.63K
May 11May 28Jun 16Jul 6Jul 23Aug 10
LEMAITRE VASCULAR INCSURGICAL & MEDICAL INSTRUMENTS & APPARATUSwww.lemaitre.com ↗
Price81.12
Change-0.41%
Gap-0.25%
Rel volume3.55×
Avg volume448.92K
Avg $ vol40.47M
SMA 2096.83
SMA 5096.13
SMA 20095.64
Price vs 50-15.61%
Price vs 200-15.18%
MA stackmixed
50/200 cross—
Supertrenddown · 97.21
RSI (14)32
MACD hist-2.56
MACD crossbear · 3d
Stoch %K / %D9 / 9
ADX (14)22
+DI / −DI14 / 37
RSI divergence—
MACD divergence—
ATR %+6.13%
ADR %4.20%
52w high117.39
52w low79.00
From 52w high-30.90%
Above 52w low+2.68%
New 52w highNo
SqueezeOff
Bollinger width34.90%
%B0.04
Donchian pos8.95%
Donchian high106.26
Donchian low78.65
AVWAP (52w high)96.97
vs AVWAP high-16.34%
AVWAP (52w low)81.78
vs AVWAP low-0.81%
OBV trendDown
Chaikin MF (20)-0.19
Today vs 20d3.55×
Avg vol (14d)546.63K
Avg vol (20d)448.92K
Avg $ vol (20d)40.47M
Market cap1.86B
RS 3m (vs SPY)-30.22%
RS 6m (vs SPY)-20.48%
RS line new highNo
Trend template2/8
Technical rank19.3
1 week-21.71%
1 month-21.04%
3 months-24.85%
6 months-7.21%
1 year-13.94%
YTD+1.18%
P/E32.13
P/B4.41
P/S7.43
P/FCF23.66
EPS2.52
Div yield0.98%
ROE13.73%
ROA9.01%
Debt/Eq—
Current16.31
EV/EBITDA23.34
Gross margin71.53%
Net margin23.13%
Rev growth13.53%
EPS growth31.10%
Price target103.00
Target upside26.97%
Analyst ratingBuy
Institutional104.50%
Ent. value1.83B
Revenue54.82M
Net income17.05M
Gross profit50.76M
Free cash flow78.41M
IndustrySURGICAL & MEDICAL INSTRUMENTS & APPARATUS
ExchangeNasdaq
Shares out22.85M
Employees655
ListedThu, Oct 19, 2006
Free float21.15M
Float %92.6%
Short interest1.48M
Days to cover4.5d
Short volume41.4%
Squeeze score52 / 100
Next earnings—
EPS forecast—
Last EPS vs est$0.74 vs $0.81
Last surprise-8.6% miss
Setup gradeD
Conviction38 / 100
Pattern quality—
Tech rank19.3 / 100
Group rank86 / 100 · Leading
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmBearish harami
News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in LMAT

All disclosures →
No recent disclosed trades by Congress in LMAT. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in LMAT · 10 buys

InsiderSideShares
Pellegrino Joseph P JR
Director · Dividend Equivalent Rights · 2026-06-04
Grant1.427
Roberts David B
President and Director · Dividend Equivalent Rights · 2026-06-04
Grant0.297
O'Connor John James
Director · Dividend Equivalent Rights · 2026-06-04
Grant0.466
LeMaitre George W
Chairman and CEO · Dividend Equivalent Rights · 2026-06-04
Grant11.359
Jasinski Lawrence J
Director · Dividend Equivalent Rights · 2026-06-04
Grant1.427
LeBlanc Dorian Paul
Chief Financial Officer · Dividend Equivalent Rights · 2026-06-04
Grant2.476
Roberts David B
President and Director · Dividend Equivalent Rights · 2026-06-04
Grant3.068
Pellegrino Joseph P JR
Director · Dividend Equivalent Rights · 2026-06-04
Grant3.734
LeMaitre George W
Chairman and CEO · Dividend Equivalent Rights · 2026-06-04
Grant16.805
LeBlanc Dorian Paul
Chief Financial Officer · Dividend Equivalent Rights · 2026-06-04
Grant3.152

SEC filings

EDGAR filings in LMAT · 5 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.